National Comprehensive Cancer Network



About NCCN

Bladder/Penile Cancers Panel - Disclosures as of 10/8/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Neeraj Agarwal, MD

None

None

None

None

None

Matthew C. Biagioli, MD, MS

None

None

None

None

None

Peter E. Clark, MD

None

Archimedes

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Mario A. Eisenberger, MD

None

Ipsen

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Richard E. Greenberg, FACS, MD

None

Endo Pharmaceuticals

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Harry W. Herr, MD

None

None

None

None

None

Maria Ho, PhD

None

None

None

None

None

Brant A. Inman, MD, MSc

None

None

None

None

None

A. Karim Kader, MD, PhD, FRCSC

None

None

None

None

None

Deborah A. Kuban, MD

None

None

None

Immtech International, Inc.

None

Timothy M. Kuzel, MD

None

Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Elorac;
Prometheus Laboratories;
Pfizer Inc.

None

None

None

Subodh M. Lele, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Jeff Michalski, MD, MBA

None

None

None

None

None

Jeffrey S. Montgomery, MD, MHSA

None

None

None

None

None

Lance C. Pagliaro, MD

None

None

None

None

None

Sumanta K. Pal, MD

None

Dendreon Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Astellas;
Aveo;
Pfizer Inc.

None

None

None

Anthony Patterson, MD

None

None

None

None

None

Elizabeth R. Plimack, MD, MS

None

Dendreon Corporation;
GlaxoSmithKline;
Astellas

None

None

None

Kamal S. Pohar, MD

None

None

None

None

None

Michael P. Porter, MD, MS

None

None

None

None

None

Jerome Paul Richie, MD

None

None

None

None

None

Wade J. Sexton, MD

Endo Pharmaceuticals

Endo Pharmaceuticals

None

None

None

William U. Shipley, MD, FACR

None

None

None

Pfizer Inc.

None

Eric J. Small, MD

None

Dendreon Corporation

None

None

None

Guru Sonpavde, MD

None

Amgen Inc.;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

None

Philippe E. Spiess, MD

None

None

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Donald L. Trump, MD, FACP

None

None

None

None

None

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

None

Geoffrey Wile, MD

None

None

None

None

None

Timothy G. Wilson, MD

None

None

None

None

None